Sign In
Free Newsletter
C.R. Bard to Repurchase Some 500 Million of Stock
Jessica Perry//December 16, 2005
The action will replace the 1,150,800 shares remaining under the companyÂs earlier buyback plan.The board of directors of C.R. Bard (NYSE: BCR), a Murray Hill-based manufacturer of medical technologies, has authorized the repurchase of up to $500 million of the companyÂs common stock. This move will replace the 1,150,800 shares remaining under the companyÂs most recent buyback authorization of 5 million shares, which was approved in December 2002.
The company says it will continue to repurchase shares through the open market and privately negotiated transactions from time to time. C.R. Bard stock rose $0.53, or 0.79%, to $67.44 in morning trading.
